RA Capital Management - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$48,368,986
-17.3%
4,417,2590.0%0.95%
-13.8%
Q2 2023$58,484,509
-2.7%
4,417,2590.0%1.10%
-18.9%
Q1 2023$60,118,895
-30.3%
4,417,2590.0%1.36%
-22.2%
Q4 2022$86,269,068
+2.5%
4,417,2590.0%1.75%
-2.5%
Q3 2022$84,149,000
-7.5%
4,417,2590.0%1.80%
-26.0%
Q2 2022$90,996,000
-36.0%
4,417,2590.0%2.43%
-21.8%
Q1 2022$142,147,000
-30.9%
4,417,2590.0%3.10%
-14.5%
Q4 2021$205,668,000
+72.4%
4,417,2590.0%3.63%
+119.4%
Q3 2021$119,266,000
+5.3%
4,417,2590.0%1.65%
-9.1%
Q2 2021$113,303,000
-25.0%
4,417,259
+0.0%
1.82%
-20.1%
Q1 2021$150,982,000
+1.1%
4,417,2580.0%2.28%
+9.1%
Q4 2020$149,392,000
+37.1%
4,417,2580.0%2.09%
+4.8%
Q3 2020$108,974,0004,417,2581.99%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders